Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis

NCT00525902 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Adalimumab

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]